Cochrane review of capecitabine for hormone receptor positive versus hormone receptor negative breast cancer

A. Redfern, P. Lau, Andrew White, S. Hoon, M. Bulsara, A. Long

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

Original language	English
Number of pages	2
Journal	Cancer Research
Volume	77
DOIs	https://doi.org/10.1158/1538-7445.SABCS16-P2-12-02
Publication status	Published - Feb 2017
Event	San Antonio Breast Cancer Symposium - San Antonio Duration: 6 Dec 2016 → 10 Dec 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{09028f30d293407b94f5aac38f56201a,

title = "Cochrane review of capecitabine for hormone receptor positive versus hormone receptor negative breast cancer",

author = "A. Redfern and P. Lau and Andrew White and S. Hoon and M. Bulsara and A. Long",

year = "2017",

month = feb,

doi = "10.1158/1538-7445.SABCS16-P2-12-02",

language = "English",

volume = "77",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research (AACR)",

note = "San Antonio Breast Cancer Symposium ; Conference date: 06-12-2016 Through 10-12-2016",

}

TY - JOUR

T1 - Cochrane review of capecitabine for hormone receptor positive versus hormone receptor negative breast cancer

AU - Redfern, A.

AU - Lau, P.

AU - White, Andrew

AU - Hoon, S.

AU - Bulsara, M.

AU - Long, A.

PY - 2017/2

Y1 - 2017/2

U2 - 10.1158/1538-7445.SABCS16-P2-12-02

DO - 10.1158/1538-7445.SABCS16-P2-12-02

M3 - Abstract/Meeting Abstract

SN - 0008-5472

VL - 77

JO - Cancer Research

JF - Cancer Research

T2 - San Antonio Breast Cancer Symposium

Y2 - 6 December 2016 through 10 December 2016

ER -